Detalles de la búsqueda
1.
Cardiac safety results from a phase II, open-label, multicenter, pilot study of two docetaxel-based regimens plus bevacizumab for the adjuvant treatment of subjects with node-positive or high-risk node-negative breast cancer.
Springerplus
; 3: 244, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-24860718
Resultados
1 -
1
de 1
1
Próxima >
>>